365 related articles for article (PubMed ID: 38779674)
1. Sterile inflammation of peritoneal membrane caused by peritoneal dialysis: focus on the communication between immune cells and peritoneal stroma.
Su H; Zou R; Su J; Chen X; Yang H; An N; Yang C; Tang J; Liu H; Yao C
Front Immunol; 2024; 15():1387292. PubMed ID: 38779674
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells-Peritoneal Stroma Interactions.
Terri M; Trionfetti F; Montaldo C; Cordani M; Tripodi M; Lopez-Cabrera M; Strippoli R
Front Immunol; 2021; 12():607204. PubMed ID: 33854496
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
[TBL] [Abstract][Full Text] [Related]
4. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
Park MS
Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
[TBL] [Abstract][Full Text] [Related]
5. IL-17A is a novel player in dialysis-induced peritoneal damage.
Rodrigues-Díez R; Aroeira LS; Orejudo M; Bajo MA; Heffernan JJ; Rodrigues-Díez RR; Rayego-Mateos S; Ortiz A; Gonzalez-Mateo G; López-Cabrera M; Selgas R; Egido J; Ruiz-Ortega M
Kidney Int; 2014 Aug; 86(2):303-15. PubMed ID: 24552849
[TBL] [Abstract][Full Text] [Related]
6. PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.
Sandoval P; Loureiro J; González-Mateo G; Pérez-Lozano ML; Maldonado-Rodríguez A; Sánchez-Tomero JA; Mendoza L; Santamaría B; Ortiz A; Ruíz-Ortega M; Selgas R; Martín P; Sánchez-Madrid F; Aguilera A; López-Cabrera M
Lab Invest; 2010 Oct; 90(10):1517-32. PubMed ID: 20531289
[TBL] [Abstract][Full Text] [Related]
7. Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
Raby AC; González-Mateo GT; Williams A; Topley N; Fraser D; López-Cabrera M; Labéta MO
Kidney Int; 2018 Aug; 94(2):346-362. PubMed ID: 29861057
[TBL] [Abstract][Full Text] [Related]
8. Persistent sterile peritoneal inflammation after catheter removal for refractory bacterial peritonitis predicts full-blown encapsulating peritoneal sclerosis.
Wong YY; Wong PN; Mak SK; Chan SF; Cheuk YY; Ho LY; Lo KY; Lo MW; Lo KC; Tong GM; Wong AK
Perit Dial Int; 2013; 33(5):507-14. PubMed ID: 23907832
[TBL] [Abstract][Full Text] [Related]
9. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
Bazargani F
Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis.
Baroni G; Schuinski A; de Moraes TP; Meyer F; Pecoits-Filho R
Mediators Inflamm; 2012; 2012():912595. PubMed ID: 22547910
[TBL] [Abstract][Full Text] [Related]
11. Sterile solutions and peritoneal inflammation.
Flessner MF
Contrib Nephrol; 2006; 150():156-165. PubMed ID: 16721006
[TBL] [Abstract][Full Text] [Related]
12. Mediators of inflammation and fibrosis.
Lai KN; Tang SC; Leung JC
Perit Dial Int; 2007 Jun; 27 Suppl 2():S65-71. PubMed ID: 17556333
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
14. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.
Aroeira LS; Aguilera A; Sánchez-Tomero JA; Bajo MA; del Peso G; Jiménez-Heffernan JA; Selgas R; López-Cabrera M
J Am Soc Nephrol; 2007 Jul; 18(7):2004-13. PubMed ID: 17568021
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic cells: mesothelial cells -- central players in regulating inflammation and resolution.
Yung S; Chan TM
Perit Dial Int; 2009 Feb; 29 Suppl 2():S21-7. PubMed ID: 19270220
[TBL] [Abstract][Full Text] [Related]
16. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.
Cameron JS
Pediatr Nephrol; 1995 Oct; 9(5):647-62. PubMed ID: 8580033
[TBL] [Abstract][Full Text] [Related]
17. Inflammation from sterile dialysis solutions and the longevity of the peritoneal barrier.
Flessner MF
Clin Nephrol; 2007 Dec; 68(6):341-8. PubMed ID: 18184514
[TBL] [Abstract][Full Text] [Related]
18. Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions.
Mortier S; De Vriese AS; Lameire N
Blood Purif; 2003; 21(1):14-23. PubMed ID: 12566656
[TBL] [Abstract][Full Text] [Related]
19. Factors contributing to peritoneal tissue remodeling in peritoneal dialysis.
Schilte MN; Celie JW; Wee PM; Beelen RH; van den Born J
Perit Dial Int; 2009; 29(6):605-17. PubMed ID: 19910560
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of mesothelial transplantation during experimental peritoneal dialysis and peritonitis.
Hekking LH; van den Born J
Int J Artif Organs; 2007 Jun; 30(6):513-9. PubMed ID: 17628852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
